Michael A. Rossi was named Chief Financial Officer of LENSAR, Inc., effective May 29, 2026. As of November 6, 2026, LENSAR, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 15, 2026 to May 29, 2026, naming 1 appointment and 1 departure (Form 8-K, May 29, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like LENSAR, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
LENSAR, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-15 to 2026-05-29. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as LENSAR, Inc. files it.
Also on the record for LENSAR, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 29, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 1.5% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by BRANDES INVESTMENT PARTNERS, LP | 8.5% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G, by BRANDES INVESTMENT PARTNERS, LP | 6.5% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs LENSAR, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on LENSAR, Inc. and the records around it.
LENSAR, Inc. elsewhere on the record
Companies that share a holder
- BRANDES INVESTMENT PARTNERS, LP also filed stake reports on 26 other companies: Globant S.A. (Oct 2026), American Outdoor Brands, Inc. (Aug 2026), HURCO COMPANIES INC (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch LENSAR, Inc.
Get an email when LENSAR, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on LENSAR, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on LENSAR, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LENSAR, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-29 | In | Chief Financial Officer | 2026-05-29 | 8-K, 2026-05-29 | |
| 2026-04-15 | Out | Chief Financial Officer | 2026-05-08 | 8-K, 2026-04-15 |
Who leads LENSAR, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Michael A. Rossi, appointed, effective 2026-05-29 (filed 2026-05-29).
New leaders reset buying decisions — get the Full Report on LENSAR, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at LENSAR, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at LENSAR, Inc.Every change, in the filing's words
Appointed: Michael A. Rossi, Chief Financial Officer, effective 2026-05-29
On May 25, 2026, the Board of Directors (the "Board") of LENSAR, Inc. (the "Company") appointed Michael A. Rossi to serve as the Company's Interim Chief Financial Officer and principal financial officer, effective as of May 29, 2026.
- Mr. Rossi, 52, previously served as Chief Financial Officer of Access Vascular, Inc., an early commercial stage medical device company, from March 2025 to July 2025 after having served as a consulting CFO for Access Vascular from April 2024 to February 2025.
- He served as Chief Financial Officer of ConcertAI LLC, a data, software and AI company serving life sciences and healthcare, from February 2023 to September 2023.
- Prior to these roles, Mr. Rossi served as Chief Financial Officer of Harvard Bioscience, Inc. (Nasdaq: HBIO), a life science tools company, from July 2019 to December 2022, and as Chief Financial Officer of various other companies within the healthcare industry.
- Mr. Rossi brings significant experience with turnarounds and driving financial and operational improvements within complex middle market healthcare businesses.
- He also has over twenty years of public company and private equity finance and accounting experience as well as experience driving strategic acquisitions and managing debt and liquidity during both periods of growth and business downturns.
- Earlier in his career, Mr. Rossi held finance roles of increasing responsibility at various public companies, and he began his professional career as an accountant at PricewaterhouseCoopers.
- Mr. Rossi earned a B.S. in accounting from Babson College and an MBA from Babson College's Olin School of Management.
Departing: Thomas R. Staab, Chief Financial Officer, effective 2026-05-08
On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc. (the "Company"), notified the Company of his intention to resign from this position, effective May 8, 2026 (the "Transition Date"), to pursue other professional opportunities.
- Mr. Staab will continue serving as the Company's principal financial officer through the Transition Date.
- Mr. Staab's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- The Company has commenced a search for a new Chief Financial Officer.
Tools for this story
Each opens in a new tab, filled in for LENSAR, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.